Multidisciplinary Research Training in Palliative Care

姑息治疗的多学科研究培训

• 批准号: 8666995
• 负责人: JEAN S KUTNER
• 金额: $ 13.16万
• 依托单位: UNIVERSITY OF COLORADO DENVER
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-05-01 至 2019-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8666995
• 关键词: Interdisciplinary Study; Palliative Care; Research Training

DESCRIPTION (provided by applicant): Project Summary / Abstract Although clinical palliative care fellowship programs have been growing in number and quality, there is a paucity of research training opportunities in palliative care1 with reports from the Institute of Medicine and National Institutes of Health highlighting the need for basic, translational, clinical, and heath services research in palliative care. 2 3 4 5,6 One of the most important ways to advance care for older adults with advanced illness is to develop junior investigators. Such training is necessary to build the academic infrastructure required for continued evidence-based growth of the field. Recognizing this need, a 2012 joint statement from the American Geriatrics Society (AGS) and American Academy of Hospice and Palliative Medicine (AAHPM) recommended increased collaboration between palliative and geriatric medicine in workforce, education, research, and policy. 7 Given existing expertise, a critical mass of experienced investigators, and longstanding close collaborations between palliative care and geriatrics, the University of Colorado is uniquely qualified to address this urgent need through a T32 palliative care research training grant. The goal of this T32 is to prepare postdoctoral fellows for careers as palliative care researchers. This is accomplished by recruiting exceptional and committed applicants and exposing them to an environment which features dedicated, experienced, and outstanding Program Faculty who will serve as senior mentors and affiliated faculty who will serve as junior/co-mentors. These faculty represent key disciplines and resources essential for palliative care research: the Schools of Medicine, Pharmacy and Public Health, the College of Nursing, the Colorado Health Outcomes Program, the Center for Bioethics and Humanities, the Department of Psychology, the Kaiser Institute for Health Research, National Jewish Health, and the resources of the Colorado Clinical and Translational Sciences Institute (CCTSI), the University of Colorado CTSA. From the School of Medicine, key connections and collaborations are between the Divisions of General Internal Medicine, Geriatric Medicine and Health Care Policy and Research. The specific objectives of this training program are to: 1) recruit and retain outstanding post-doctoral trainees; 2) support their research training through experiential and didactic instruction; 3) ensure the highest level of academic success through conscientious monitoring of a thoughtfully constructed personalized research career development plan; and 4) enhance the mentoring skills of junior mentors through co-mentoring with more experienced senior mentors, expanding the cohort of senior mentors in palliative care research. These objectives will be carried out by offering: 1) 2 years of research training support for 4-post-doctoral trainees per year; 2) expert mentoring by experienced senior mentors (Program Faculty) with co-mentoring by less experienced investigators (Affiliated Faculty) ; 3) relevant formal coursework tailored to the needs and prior training of individual fellows; 4) regularly scheduled research and career development seminars; 5) integration of trainees into the existing Program in Palliative Care Research activities and resources; 6) frequent and careful review of trainee progress/success, incorporating feedback to and from trainees; 7) ongoing appraisal of the program goals, strength and weaknesses; and 8) sound financial and administrative oversight. Our success will be evidenced by our ability to: 1) fill our positions wih outstanding trainees and foster an ongoing pipeline of trainee candidates; 2) produce academically successful and productive trainees; 3) expand the cohort of palliative care research mentors by engaging more junior faculty as co-mentors with a goal of transitioning them to Program Faculty / senior mentors as they gain experience/expertise; and 4) expand palliative care research capacity through deliberate and strategic interactions amongst programs and faculty, bringing new skills and expertise to and engaging new senior mentors in palliative care research. Of the 52 institutional training grants at the University of Colorado, ths is the only one specifically dedicated to palliative care research. Nationally, only 2 institutiona research training awards (T32) focus on palliative care, and both are limited to cancer (NIH RePORT, accessed 5/19/13).

描述（由申请人提供）：项目摘要/摘要 尽管临床姑息治疗奖学金计划在数量和质量上都在不断增长，但姑息治疗方面的研究培训机会却很少1，医学研究所和国立卫生研究院的报告强调了姑息治疗方面的研究培训机会姑息治疗方面的基础、转化、临床和健康服务研究的需求。 2 3 4 5,6 推进对患有晚期疾病的老年人的护理的最重要方法之一是培养初级研究者。这种培训对于建立该领域持续循证发展所需的学术基础设施是必要的。认识到这一需求，美国老年医学会 (AGS) 和美国临终关怀与姑息医学学会 (AAHPM) 于 2012 年发表联合声明，建议加强姑息医学与老年医学在劳动力、教育、研究和政策方面的合作。 7 鉴于现有的专业知识、大量经验丰富的研究人员以及姑息治疗和老年病学之间的长期密切合作，科罗拉多大学拥有独特的资格，可以通过 T32 姑息治疗研究培训拨款来满足这一迫切需求。 T32 的目标是为博士后研究员作为姑息治疗研究人员的职业做好准备。这是通过招募优秀和忠诚的申请者并将他们暴露在一个以敬业、经验丰富和杰出的项目教师为特色的环境中来实现的，这些教师将担任高级导师，附属教员将担任初级/联合导师。这些教师代表了姑息治疗研究所必需的关键学科和资源：医学院、药学和公共卫生学院、护理学院、科罗拉多州健康成果计划、生物伦理学和人文中心、心理学系、凯撒研究所健康研究、国家犹太健康以及科罗拉多临床和转化科学研究所 (CCTSI)、科罗拉多大学 CTSA 的资源。在医学院，普通内科、老年医学和卫生保健政策与研究等部门之间有着重要的联系和合作。该培训计划的具体目标是： 1) 招募和保留 优秀博士后； 2）通过体验式和教学式指导支持他们的研究培训； 3）通过认真监控精心构建的个性化研究职业发展计划，确保最高水平的学术成功； 4）通过与更有经验的高级导师共同指导，提高初级导师的指导技能，扩大姑息治疗研究的高级导师队伍。这些目标将通过以下方式实现：1）每年为4名博士后学员提供2年的研究培训支持； 2) 由经验丰富的高级导师（项目教员）进行专家指导，并由经验较少的研究人员（附属教员）共同指导； 3）根据个别研究员的需要和事先培训量身定制的相关正式课程； 4）定期举办研究和职业发展研讨会； 5) 将学员纳入现有的姑息治疗研究活动和资源计划； 6) 经常、仔细地审查受训者的进展/成功，纳入受训者的反馈； 7) 持续评估项目目标、优势和劣势； 8) 健全的财务和行政监督。我们的成功将通过我们的能力来证明：1）用优秀的实习生填补我们的职位，并培养持续的实习生候选人渠道； 2）培养学术上成功且富有成效的学员； 3) 通过聘请更多初级教师作为共同导师，扩大姑息治疗研究导师队伍，目标是随着他们获得经验/专业知识，将他们转变为项目教师/高级导师； 4) 通过项目和教师之间的深思熟虑和战略互动，扩大姑息治疗研究能力，为姑息治疗研究带来新的技能和专业知识，并吸引新的高级导师参与。在科罗拉多大学的 52 项机构培训资助中，这是唯一一项专门用于姑息治疗研究的资助。在全国范围内，只有 2 个机构研究培训奖 (T32) 专注于姑息治疗，并且都仅限于癌症（NIH 报告，2013 年 5 月 19 日访问）。